Our People

Juliet French

Professor | Program Director of Cancer Research |
Group Leader of Functional Genetics

Functional Genetics

+61 7 3845 3028

juliet.french@qimrberghofer.edu.au

 

CAREER HISTORY

Professor Juliet French is the Program Director of Cancer Research and Head of the Functional Genetics Laboratory at QIMR Berghofer. She completed her PhD in 2003 at the Institute of Molecular Bioscience, University of Queensland and continued her post-doctoral studies in the School of Molecular Biosciences.  She moved to QIMR Berghofer as a Team Head in 2013 and was promoted to Group Leader in 2018 where she heads a research group aimed at understanding how genetic variants in non-coding regions of the genome influence cancer risk and progression. 

 

CURRENT APPOINTMENTS

2023-current: Program Director of Cancer Research, QIMR Berghofer

2013-current: Group Leader Functional Genetics Laboratory, QIMR Berghofer

 

PREVIOUS APPOINTMENTS

2018-2023: Deputy Coordinator, Genetic & Computational Biology Department, QIMR Berghofer

2003-2012: Postdoctoral Fellow, University of Queensland

 

ORCID NUMBER

0000-0002-9770-0198

 

RESEARCHER ID

AAV-4435-2020

 

CURRENT AREA OF RESEARCH

Professor Juliet French is a molecular biologist and Head of the Functional Genetics Laboratory at QIMR Berghofer. Her research focuses on understanding how genetic variants in non-coding regions of the genome influence cancer risk and progression. Until recently, the genetic basis of cancer has only been examined in coding regions, which accounts for less than two percent of the human genome.  However, noncoding regions are littered with functional elements such as transcriptional enhancers and long non-coding RNAs.  The laboratory focuses on how inherited variants identified through genome wide association studies (GWAS) and cancer specific mutations identified through whole gene sequencing (WGS) can alter these non-coding elements to promote the development of cancer. The ultimate aim is to use genetics to pinpoint the key genes and pathways implicated in the development of cancer to identify new therapeutic opportunities.

 

PROFESSIONAL MEMBERSHIPS

2013-current:  American Society of Human Genetics

2012-current:  Kathleen Cuningham Foundation Consortium for research into Familial Breast Cancer

 

AWARDS RECOGNITION

2019: Isabel and Roderic Allpass Fellow

2012-2016: NBCF Early Career Fellowship

2006-2010: NBCF Post-doctoral Training Fellowship

 

EDUCATIONAL BACKGROUND

2003: Doctor of Philosophy, IMB, University of Queensland

1997: Bachelor of Science (Honours), IMB, University of Queensland